Meribel Pharma Solutions Overview
- Year Founded
-
2001
- Status
-
Private
- Employees
-
2,000
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
6
- Investments
-
5
Meribel Pharma Solutions General Information
Description
Operator of a mid-sized contract development and manufacturing organization (CDMO) dedicated to providing improved quality and efficient packaging. The company specializes in the production and contract packaging of drugs, medical devices, and food supplements, along with drug formulation, analytical, and galenic expertise, ensuring its clients get support throughout the drug development life cycle from formulation to industrialization effectively.
Contact Information
Website
www.meribelpharma.comCorporate Office
- 201 Bishopsgate
- Suite 7G
- London EC2M 3AB
- England, United Kingdom
Corporate Office
- 201 Bishopsgate
- Suite 7G
- London EC2M 3AB
- England, United Kingdom
Meribel Pharma Solutions Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Meribel Pharma Solutions Comparisons
Industry
Financing
Details
Meribel Pharma Solutions Competitors (20)
One of Meribel Pharma Solutions’s 20 competitors is CordenPharma, a Private Equity-Backed company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CordenPharma | Private Equity-Backed | Basel, Switzerland | ||||
| Cenexi | Formerly PE-Backed | Fontenay-Sous-Bois, France | ||||
| Groupe Parima | Corporation | Saint-Laurent, Canada | ||||
| Vetter Pharma | Private Debt Financed | Ravensburg, Germany | ||||
| 3PBiovian | Private Equity-Backed | Turku, Finland |
Meribel Pharma Solutions Signals
Meribel Pharma Solutions Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Meribel Pharma Solutions Investments (5)
Meribel Pharma Solutions’s most recent deal was a Buyout/LBO with Laboratorios Alcalá Farma. The deal was made on 18-Nov-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Laboratorios Alcalá Farma | 18-Nov-2015 | Buyout/LBO | Pharmaceuticals | ||
| Lyofal | 12-Nov-2012 | Buyout/LBO | Personal Products | ||
| Synerlab Développement | 12-Nov-2012 | Buyout/LBO | Pharmaceuticals | ||
| Pharmaster Plus | 19-Apr-2010 | Buyout/LBO | Pharmaceuticals | ||
| SOPHARTEX Laboratories | 01-Jan-2004 | Buyout/LBO | Other Pharmaceuticals and Biotechnology |
Meribel Pharma Solutions FAQs
-
When was Meribel Pharma Solutions founded?
Meribel Pharma Solutions was founded in 2001.
-
Where is Meribel Pharma Solutions headquartered?
Meribel Pharma Solutions is headquartered in London, United Kingdom.
-
What is the size of Meribel Pharma Solutions?
Meribel Pharma Solutions has 2,000 total employees.
-
What industry is Meribel Pharma Solutions in?
Meribel Pharma Solutions’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Meribel Pharma Solutions a private or public company?
Meribel Pharma Solutions is a Private company.
-
What is the current valuation of Meribel Pharma Solutions?
The current valuation of Meribel Pharma Solutions is .
-
What is Meribel Pharma Solutions’s current revenue?
The current revenue for Meribel Pharma Solutions is .
-
How much funding has Meribel Pharma Solutions raised over time?
Meribel Pharma Solutions has raised $182M.
-
Who are Meribel Pharma Solutions’s investors?
Blue Wolf Capital Partners has invested in Meribel Pharma Solutions.
-
Who are Meribel Pharma Solutions’s competitors?
CordenPharma, Cenexi, Groupe Parima, Vetter Pharma, and 3PBiovian are some of the 20 competitors of Meribel Pharma Solutions.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process